Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
-
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
-
PesoRama Announces Exercise of Over-Allotment Option and Issuance of Warrants
-
Playground Ventures Appoints New Director and Advisor
-
Form 8.3 - [CareTech Holdings plc 09 03 2022] - (CGWL)
-
Paragon 28 to Present at Upcoming Canaccord Genuity Musculoskeletal Conference and Needham Healthcare Conference
-
Sustainable Real Estate Dividend Fund Announces Exchange Ratios
-
PowerFleet (PWFL) PT Lowered to $9 at Canaccord Genuity
-
Natera (NTRA) Weakness on Short Report 'Overdone' - Canaccord Genuity
-
SPC Nickel Closes First Tranche of Flow Through Unit Private Placement
-
Neuronetics (STIM) PT Lowered to $9 at Canaccord Genuity
-
New York Chapter of Global M&A Association Appoints Advisory Board Leadership
-
New York Chapter of Global M&A Association Appoints Advisory Board Leadership
-
The Beauty Health Company (SKIN) Launches Syndeo - Canaccord Genuity
-
UPDATE: Canaccord Genuity Starts Lion Electric (LEV) at Buy
-
RETRANSMISSION: HIVE Blockchain Provides Update on February 2022 Production and At-The-Market Offering and Conclusion of Canadian At-The-Market Offering
-
Form 8.3 - [CareTech Holdings plc - 07 03 2022] - (CGWL)
-
HIVE Blockchain Technologies (HIVE) Produced 244.4 BTC and 1,814 ETH in February 2022; Concludes Canadian ATM
-
Form 8.3 - [Clinigen Group plc - 07 03 2022] - (CGWL)
-
Atalaya Mining PLC Announces Notice of 2021 Results and Investor Presentation
-
HIVE Blockchain Provides Update on February 2022 Production and At-The-Market Offering and Conclusion of Canadian At-The-Market Offering
-
Aytu BioPharma Announces Closing of $7.6 Million Registered Offering
-
NextPoint Financial To Participate In Canaccord Genuity Digital Disruptor Conference Addressing Online Lending on March 8, 2022
-
Canaccord Genuity Downgrades Openpay Group (OPY:AU) to Hold
-
Iris Energy to Participate at Upcoming Investor Conferences
-
Iris Energy to Participate at Upcoming Investor Conferences
-
AeroVironment (AVAV) Upgraded to Buy at Canaccord Genuity, Company's Product Seen as an 'Ideal Instrument' in War Against Russian Tanks
-
WonderFi Announces Approval to List the Warrants Issued in Connection with Its Previously Closed $26.4 Million Bought Deal Private Placement
-
Tricon Residential inc. (TCN) PT Raised to $17 at Canaccord Genuity
-
Canaccord Genuity Upgrades Hexo Corp. (HEXO:CN) (HEXO) to Spec. Buy
-
Canaccord Genuity Downgrades Argonaut Gold (AR:CN) (ARNGF) to Hold
-
Goodbody Health Announces Normal Course Issuer Bid and Restricted Share Unit Plan
-
Form 8.3 - [Clinigen Group plc - 03 03 2022] - (CGWL)
-
UPDATE: Canaccord Genuity Upgrades AeroVironment (AVAV) to Buy
-
UPDATE: Canaccord Genuity Upgrades Tilray (TLRY) to Buy
-
Thor Exploration Ltd: Director Dealing
-
Nevada Silver Corporation Announces $7 Million Brokered Private Placement
-
Canaccord Genuity Upgrades Q4 Inc. (QFOR:CN) to Spec. Buy
-
Tilray, Inc. (TLRY) Announces Proposed Agreement for Strategic Alliance With Hexo Corp. (HEXO)
-
Lifetime Brands (LCUT) Acquires S’well
-
Lifetime Brands Acquires S’well®
-
HEXO and Tilray Brands Agree to Create Strategic Alliance Bringing Together Two Canadian Cannabis Leaders
-
Bitfarms to Present at Upcoming Investor Conferences
-
HEXO and Tilray Brands Agree to Create Strategic Alliance Bringing Together Two Canadian Cannabis Leaders
-
Tilray Brands Announces Proposed Agreement for Strategic Alliance With Hexo Corp.
-
Bitfarms to Present at Upcoming Investor Conferences
-
Tilray Brands Announces Proposed Agreement for Strategic Alliance With Hexo Corp.
-
Form 8.3 - [Clinigen Group plc - 02 03 2022] - (CGWL)
-
Aytu BioScience (AYTU) Prices 3.03M Share and Warrant Offering at $1.25/sh
-
Aytu BioPharma Announces Pricing of $7.6 Million Registered Offering

